Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 22,182 shares at $13.05 ($289K) on 2024-11-21, disclosed to the SEC on 2024-11-25.
Open-market sale of $289k RCKT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.05 | 11,091 | $145K | 50.0% |
| 2 | $13.05 | 11,091 | $145K | 50.0% |
| Total | $13.05 avg | 22,182 | $289K | 100% |
| Filing → |
| RCKT | SELL | 2026-05-26 | $172K | — | Filing → |
| RCKT | SELL | 2026-05-21 | $7K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $10K | — | Filing → |